Investors in Life Science

SCVC (Science Creates Venture Capital) specializes in investing in advanced technologies ranging from biotech to quantum tech. They partner with companies that share their mission of enhancing global health and sustainability. As a team of deep tech enthusiasts and serial entrepreneurs, SCVC supports like-minded founders who are driven to make a significant impact. Operating as the official VC arm of Science Creates, SCVC provides access to a specialized ecosystem encompassing incubators, investment opportunities, strategic partnerships, and tailored programs tailored for deep tech startups. Their focus is on nurturing innovation and accelerating the growth of technologies that address critical global challenges.

Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. They balance the therapeutic focus with investments in medical devices, diagnostics, or drug delivery systems. In their investments, they look for unmet needs and clinical impact, novel proprietary science, an understanding of mechanism, management and board experience, and capital efficiency in the program. Novartis Venture Fund prefers to have their initial investment at the early stage to build the company and follow with additional investment in pace with the company's progress.

OHA Osnabrück Healthcare Accelerator support startups from the entire healthcare sector. At OHA we support startups from the healthcare industry and life sciences. We are convinced that a future-proof healthcare system must be more digital, collaborative and diverse.

Merck Accelerator program supports startups in the fields of healthcare, life science, performance materials and additional search fields. We are Merck, a vibrant science and technology company. Science is at the heart of everything we do. We are Merck, a leading global science and technology company headquartered in Germany.

Corinthian Venture Partners, founded in 2020 and based in Oslo, Norway, is a venture capital firm that focuses on seed-stage, early-stage, and later-stage investments. They primarily invest in companies within the renewable energy, life sciences, and technology sectors in the Nordic region. The firm typically invests around 2.83 million USD per investment round, with an average of one investment per year.

BioInnovation Institute Venture House provides Add-on funding opportunity for companies. BioInnovation Institute (BII) offers life science researcher and entrepreneurs access to a vibrant life science community with 3500 square meter of advanced lab and office facilities, business acceleration programs, commercial support, funding opportunities and access to high-level mentoring and networks. Bringing ideas to life and research to market.

The cluster organisation for Catalonia's healthcare and life sciences sector. Biocat is the institution that promotes the life sciences and healthcare ecosystem in Catalonia and works to maximize its economic and social impact. Biocat’s strategy focuses on positioning the BioRegion of Catalonia as one of the leading European hubs, offering researchers and professionals innovative capacity with programs to improve talent and entrepreneurship, accelerating technology transfer and business growth by supporting TTOs and startups, and helping attract investors and investment to the ecosystem.

Bio4Dreams is a privately funded certified incubator for innovative startups in very early stage phase, dedicated to Life Sciences. Certified incubator for very early stage startups dedicated to Life Sciences. Bio4Dreams is a business nursery and an international aggregator specific to Life Sciences, which supports researchers and young entrepreneurs during the very early stages of their projects.

ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients. ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.

Research center in nanoelectronics. Imec is a world-leading R&D and innovation hub in nanoelectronics and digital technologies. At times, we shape the future. Founded in 1984, imec quickly made its name as the leading research hub for advanced CMOS scaling. We will continue to shape the roadmap for the semiconductor industry for years to come.

Startup hub focussed on Life Sciences, Artificial Intelligence, and Industry Tech. The Technology Park is run by the Technologiepark Heidelberg GmbH, a joint venture by the City of Heidelberg and the Rhine-Neckar Chamber of Commerce and Industry (IHK), which with its wide-ranging services and active networking is committed to promoting the rapid growth of this base for cutting-edge science and technology.

German Accelerator empowers German startups to scale globally. We take high-potential companies on a fast-paced learning journey to understand, discover, and access the world’s leading innovation hubs in the U.S., Asia, and South America. Through highly-customized programs, mentoring from dedicated experts, as well as access to our vast network of business partners and investors.